Ozempic is approved to help manage type 2 diabetes and reduce cardiovascular risk, while Wegovy is approved to assist with weight loss and for chronic weight management (in conjunction with a reduced-calorie diet and increased physical activity) in people with obesity or who are overweight with at least one weight-related condition
Patients typically notice a looser waistband, reduced bloating, and a flatter appearance around the lower abdomen
Your health is not an area for compromise
Winkler B, Baier K, Wagner S, Repa A, Eichler HG, Scheiner O, et al
It is typically prescribed when diet, exercise, and other diabetes medications have not achieved adequate glycaemic control
The most effective options typically contain at least 98% pure BPC-157, delivered in enteric-coated capsules to enhance bioavailability 1